nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—CYSLTR2—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0218	0.0218	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0218	0.0218	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—P2RY11—narcolepsy	0.0211	0.0211	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0195	0.0195	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0195	0.0195	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0188	0.0188	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—HCRT—narcolepsy	0.0179	0.0179	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0169	0.0169	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0169	0.0169	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0163	0.0163	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.016	0.016	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0151	0.0151	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0151	0.0151	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0146	0.0146	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0144	0.0144	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0144	0.0144	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0139	0.0139	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—TRH—narcolepsy	0.0136	0.0136	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0135	0.0135	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0135	0.0135	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0131	0.0131	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—HCRT—narcolepsy	0.0124	0.0124	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0121	0.0121	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0119	0.0119	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0117	0.0117	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0117	0.0117	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—HCRTR2—narcolepsy	0.011	0.011	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—HCRTR1—narcolepsy	0.011	0.011	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—P2RY11—narcolepsy	0.0106	0.0106	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0106	0.0106	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.01	0.01	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.01	0.01	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—NPS—narcolepsy	0.00986	0.00986	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—TAC1—narcolepsy	0.00986	0.00986	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00966	0.00966	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—TRH—narcolepsy	0.0094	0.0094	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0092	0.0092	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—HCRT—narcolepsy	0.00903	0.00903	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00898	0.00898	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00882	0.00882	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00882	0.00882	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00841	0.00841	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00822	0.00822	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—PENK—narcolepsy	0.00805	0.00805	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00788	0.00788	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—HCRTR1—narcolepsy	0.00762	0.00762	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—HCRTR2—narcolepsy	0.00762	0.00762	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—P2RY11—narcolepsy	0.00736	0.00736	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00732	0.00732	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—TRH—narcolepsy	0.00684	0.00684	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—NPS—narcolepsy	0.00683	0.00683	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—TAC1—narcolepsy	0.00683	0.00683	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00653	0.00653	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00653	0.00653	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00637	0.00637	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—HCRT—narcolepsy	0.00626	0.00626	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00623	0.00623	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00621	0.00621	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00621	0.00621	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00611	0.00611	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00611	0.00611	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—P2RY11—narcolepsy	0.006	0.006	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—HRH3—narcolepsy	0.006	0.006	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—HTR2A—narcolepsy	0.00593	0.00593	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HCRTR1—narcolepsy	0.00564	0.00564	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HCRTR2—narcolepsy	0.00564	0.00564	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—PENK—narcolepsy	0.00558	0.00558	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00546	0.00546	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—P2RY11—narcolepsy	0.00545	0.00545	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0053	0.0053	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HCRT—narcolepsy	0.0051	0.0051	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—NPS—narcolepsy	0.00497	0.00497	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—TAC1—narcolepsy	0.00497	0.00497	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—TRH—narcolepsy	0.00474	0.00474	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HCRT—narcolepsy	0.00463	0.00463	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00458	0.00458	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—PENK—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00453	0.00453	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00453	0.00453	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00431	0.00431	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00431	0.00431	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—P2RY11—narcolepsy	0.00416	0.00416	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—HRH3—narcolepsy	0.00416	0.00416	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—PENK—narcolepsy	0.00413	0.00413	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00411	0.00411	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00393	0.00393	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HCRTR2—narcolepsy	0.00391	0.00391	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HCRTR1—narcolepsy	0.00391	0.00391	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—TRH—narcolepsy	0.00387	0.00387	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—P2RY11—narcolepsy	0.00378	0.00378	CbGpPWpGaD
Zafirlukast—PTGS1—Overview of nanoparticle effects—TNF—narcolepsy	0.0037	0.0037	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00368	0.00368	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HCRT—narcolepsy	0.00354	0.00354	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—TRH—narcolepsy	0.00351	0.00351	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—TAC1—narcolepsy	0.00345	0.00345	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—NPS—narcolepsy	0.00345	0.00345	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HRH3—narcolepsy	0.00339	0.00339	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HCRTR2—narcolepsy	0.00333	0.00333	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HCRTR1—narcolepsy	0.00333	0.00333	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—P2RY11—narcolepsy	0.00322	0.00322	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HCRT—narcolepsy	0.00321	0.00321	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00318	0.00318	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—PENK—narcolepsy	0.00315	0.00315	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HRH3—narcolepsy	0.00308	0.00308	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—HTR2A—narcolepsy	0.00299	0.00299	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PENK—narcolepsy	0.00286	0.00286	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—NPS—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—TAC1—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HCRT—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—TRH—narcolepsy	0.00268	0.00268	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—NPS—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—TAC1—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PENK—narcolepsy	0.00244	0.00244	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—TRH—narcolepsy	0.00243	0.00243	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HRH3—narcolepsy	0.00235	0.00235	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HCRTR2—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HCRTR1—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—P2RY11—narcolepsy	0.00223	0.00223	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HRH3—narcolepsy	0.00213	0.00213	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TRH—narcolepsy	0.00207	0.00207	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—HTR2A—narcolepsy	0.00207	0.00207	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—TAC1—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—NPS—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HCRT—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HRH3—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—NPS—narcolepsy	0.00177	0.00177	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—TAC1—narcolepsy	0.00177	0.00177	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PENK—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—HTR2A—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HTR2A—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TAC1—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NPS—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TRH—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HRH3—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HTR2A—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CHKB—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—TNF—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HTR2A—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CHKB—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NPS—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TAC1—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000928	0.000928	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HTR2A—narcolepsy	0.000907	0.000907	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000846	0.000846	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00082	0.00082	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00082	0.00082	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CHKB—narcolepsy	0.000788	0.000788	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CPT1B—narcolepsy	0.000746	0.000746	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000723	0.000723	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CPT1B—narcolepsy	0.000717	0.000717	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CHKB—narcolepsy	0.000681	0.000681	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HTR2A—narcolepsy	0.000628	0.000628	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CHKB—narcolepsy	0.000608	0.000608	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CHKB—narcolepsy	0.000559	0.000559	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CHKB—narcolepsy	0.000554	0.000554	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CPT1B—narcolepsy	0.000536	0.000536	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CHKB—narcolepsy	0.000474	0.000474	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CPT1B—narcolepsy	0.000463	0.000463	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CPT1B—narcolepsy	0.000413	0.000413	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CPT1B—narcolepsy	0.00038	0.00038	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000377	0.000377	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CHKB—narcolepsy	0.000366	0.000366	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CPT1B—narcolepsy	0.000322	0.000322	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000249	0.000249	CbGpPWpGaD
